PDS Biotechnology (PDSB) Financial Statements

822 Followers

PDS Biotechnology Financial Overview

PDS Biotechnology's market cap is currently $75.91M. The company's EPS TTM is $-0.13; its P/E ratio is -1.18; PDS Biotechnology is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Mar 22
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -60.52K	$ -59.79K	$ -57.33K	$ 0.00	$ 0.00
Operating Income	$ -31.54M	$ -36.32M	$ -43.05M	$ -41.67M	$ -21.44M
EBITDA	$ -30.30M	$ -33.75M	$ -40.09M	$ -40.74M	$ -21.43M
Net Income	$ -34.50M	$ -37.61M	$ -42.94M	$ -40.85M	$ -16.92M
Balance Sheet
Cash & Short-Term Investments	$ 26.71M	$ 41.69M	$ 56.56M	$ 73.82M	$ 65.24M
Total Assets	$ 30.49M	$ 45.36M	$ 59.39M	$ 77.01M	$ 67.20M
Total Debt	$ 5.19B	$ 21.83M	$ 23.85M	$ 23.47M	$ 490.35K
Net Debt	$ 5.17B	$ -19.86M	$ -32.71M	$ -50.35M	$ -64.75M
Total Liabilities	$ 21.24M	$ 26.35M	$ 33.26M	$ 33.01M	$ 3.99M
Stockholders' Equity	$ 9.25M	$ 19.00M	$ 26.13M	$ 44.00M	$ 63.21M
Cash Flow
Free Cash Flow	$ -27.75B	$ -35.06M	$ -33.64M	$ -25.71M	$ -12.49M
Operating Cash Flow	$ -27.75B	$ -35.03M	$ -33.64M	$ -25.71M	$ -12.49M
Investing Cash Flow	$ 0.00	$ -29.00K	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 12.77B	$ 20.19M	$ 16.38M	$ 34.29M	$ 48.89M

Currency in USD

PDS Biotechnology Earnings and Revenue History

Income Statement >

PDS Biotechnology Debt to Assets

Balance Sheet >

PDS Biotechnology Cash Flow

Cash Flow >

PDS Biotechnology Forecast EPS vs Actual EPS

Earnings >